MedPath

A study to evaluate the efficacy of D-Ppsicose on weight reduction in overweight subjects

Not Applicable
Completed
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0002081
Lead Sponsor
The Catholic University of Korea
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
99
Inclusion Criteria

99 overweight or obese patients (body mass index [BMI] between 23 kg/m2 and 30 kg/m2 ) aged between 19 and 65 years
- For women of childbearing age , negative pregnancy test during screening
- individuals agreed to participate in the study voluntarily after sufficient explanation regarding the purpose and content of study

Exclusion Criteria

The exclusion criteria included (1) Current or past history of any malignant diseases during the past 5 years ; (2) hypersensitivity to D-psicose; (3) Current psychiatric illness or psychotropic medication; (4) History of participation in any weight loss program 3 months before screening; (5) Pregnancy or breast feeding; (6) weight stable (±5%) for 3 months prior to their study participation; 7) Current use of drug that can affect the weight (weight-loss drugs, Dietary Supplements, oral corticosteroid, thyroid hormon, cyproheptadine, phenothiazine, oral contraceptive; (8) abnormal renal function or hepatic function test: and (9) The presence of diabetes or unstable cardiovascular disease.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
body fat mass change
Secondary Outcome Measures
NameTimeMethod
visceral and liver fat assessed by CT;Waist circumference;body mass index (BMI, kg/m2) and body weight;cardiovascular risk factors: fasting lipid concentrations (total cholesterol, highdensity lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, and triglycerides [TG]), glucose, insulin, and C-reactive protein;adverse events and safety
© Copyright 2025. All Rights Reserved by MedPath